Our Services
Medical Information
Helpful Resources
Published on: 10/22/2026
Stool softeners, such as docusate sodium, are a gentle type of laxative that draw water into the stool to make it easier and less painful to pass, while stimulant, osmotic, bulk-forming, and lubricant laxatives work more actively to trigger bowel movements or soften and bulk up waste. Which one is right depends on whether your constipation is occasional, chronic, or linked to hemorrhoids, recent surgery, pregnancy, or medications like opioids, and several important safety factors and timing differences are explained below. Because these products vary widely in how fast they work, how long they can be used safely, and who should avoid them, reading the complete answer below is worthwhile before choosing one. Constipation can also signal an underlying issue that no over-the-counter product will fix, so understanding the cause matters as much as finding relief. If you are unsure which option fits your situation or your symptoms have lasted more than a few days, take a free, instant online symptom check to clarify what may be driving your symptoms and what step to take next.
Last reviewed for medical accuracy: 10/22/2026
Constipation is common. Most people will experience it at some point. Two of the most popular over-the-counter remedies are stool softeners and laxatives. Understanding the stool softener vs laxative difference can help you pick the right option and avoid unnecessary discomfort or side effects.
Stool softeners (also called emollient laxatives) work by drawing water into the stool or by coating the stool’s surface. The extra moisture makes bowel movements softer and easier to pass.
Laxatives are a broad category of medicines that speed up bowel movements or change stool consistency. They come in several subtypes:
Bulk-forming laxatives
Stimulant laxatives
Osmotic laxatives
Lubricant laxatives
| Feature | Stool Softener | Laxative (Various Types) |
|---|---|---|
| Primary Action | Add moisture, soften stool | Speed up transit, bulk up or lubricate |
| Onset of Action | 12–72 hours | 15 minutes–72 hours, depending on type |
| Ease of Use | Gentle, minimal cramping | Varies: from gentle (bulk) to strong (stimulant) |
| Typical Side Effects | Mild cramps, diarrhea if misused | Cramps, gas, bloating, dependency |
| Recommended Duration | Short-term (up to 1 week) | Bulk-forming: long-term; others: short-term only |
| Best For | Preventing hard, dry stool | Treating more severe or occasional constipation |
Consider a stool softener if you:
Choose a laxative if you:
Before or alongside stool softeners and laxatives, consider lifestyle measures:
While occasional constipation is usually harmless, see a healthcare provider if you experience:
For non-urgent guidance, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help clarify next steps before you speak to a healthcare professional.
If you have serious or life-threatening symptoms, or if over-the-counter options aren’t helping within a few days, speak to a doctor right away. Your health and comfort matter—finding the right remedy shouldn’t be a struggle.
(References)
* Roach JJ. Constipation. J Natl Med Assoc. 1978 Aug;70(8):591-6. PMID: 702587; PMCID: PMC2537221.
* Roberts JW. Rectal prolapse. Clin Geriatr Med. 1985 May;1(2):445-52. PMID: 3830377.
* Gricar JA, Goodwin SA, Cave DG. Hemorrhoids. Manag Care Interface. 1998 Jun;11(6):50-2. PMID: 10181558.
* Rowan-Legg A, Canadian Paediatric Society, Community Paediatrics Committee. Managing functional constipation in children. Paediatr Child Health. 2011 Dec;16(10):661-70. PMID: 23204909; PMCID: PMC3225480.
* Mounsey A, Raleigh M, Wilson A. Management of Constipation in Older Adults. Am Fam Physician. 2015 Sep 15;92(6):500-4. PMID: 26371734.
* Albert RH. End-of-Life Care: Managing Common Symptoms. Am Fam Physician. 2017 Mar 15;95(6):356-361. PMID: 28318209.
* Patel P, Raja A. Bisacodyl. 2024 Jan. PMID: 31613513.
* Docusate. 2012. PMID: 31643530.
* Harris D, Kalir D, Chevalier C, Dobbie K, Fielding F, Lagman R, Makhoul A, McInnes S, Najafi S, Neale K, Rybicki L, Robbins-Ong M, Neuendorf K. Response Rates to Methylnaltrexone in Hospitalized Cancer Patients. Am J Hosp Palliat Care. 2023 Oct;40(10):1093-1097. doi: 10.1177/10499091221147903. Epub 2022 Dec 24. PMID: 36565253.
* Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, Valverde de Morales HG, Wang HL, Garber K, Corces V, Li H. CTCF-Related Disorder. 1993. PMID: 38662876.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.